Hisamitsu Pharmaceutical Co., Inc. (FRA:HPX)
Germany · Delayed Price · Currency is EUR 23.40
+1.20 (5.41%)
At close: Nov 28, 2025
Hisamitsu Pharmaceutical Co. Company Description
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan.
The company offers OTC products, such as, external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete′s foot; and ALLEGRA FX, a sinus medication for allergies.
It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.
It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Hisamitsu Pharmaceutical Co., Inc.
| Country | Japan |
| Founded | 1847 |
| Industry | Pharmaceutical Preparations |
| Employees | 2,799 |
| CEO | Kazuhide Nakatomi |
Contact Details
Address: Tashirodaikan-machi 408 Tosu, 841-0017 Japan | |
| Phone | 81 3 5293 1720 |
| Website | global.hisamitsu |
Stock Details
| Ticker Symbol | HPX |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | March - February |
| Reporting Currency | JPY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kazuhide Nakatomi | Chief Executive Officer |